Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study comparing two dosing algorithms for preprandial human insulin inhalation powder in insulin-naïve type 2 diabetes patients
2006-002999-17Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of human insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Eli Lilly and Company. Started Jul 2006; status: completed.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-002999-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002999-17.